Innovation
2 patent families (1 granted) — focus: Chemistry & metallurgy; filing pace active. Cited 77 times.
| Year | Filings |
|---|---|
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Social engagement
Social engagement: 3.6K social following, 5 posts in the last 12 months — below the industry typical range.
Investor mix
30 investors on record; lead investors include Hillhouse, Guangzhou Hi-Tech Communication Technology, Morningside Venture Capital, Morningside.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 13 | 43% |
| Private equity | 5 | 17% |
| Bank & private debt | 2 | 7% |
| Other / undisclosed | 10 | 33% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
14 Jan 2026 · Director to Senior Director, Quality Control · Westlake Village
2 Aug 2025 · Associate Director to Director, Biostatistics · Westlake Village
2 Aug 2025 · Senior/Executive Medical Director, Global Clinical Development · Westlake Village
Based on job postings tracked across public sources.
Recent activity
5 Jan 2026
Milestone
regulatory
8 Sep 2025
Event
ASBMR 2025
19 Aug 2025
Event
ASBMR 2025